newsfilter
← Latest News
GlobeNewswire·

Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (NASDAQ:RUBY), a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and aut